CTLA-4 — Targeted Therapies, Trials & Pipeline
An inhibitory T-cell checkpoint blocked to potentiate immune responses, often combined with anti-PD-1.
An inhibitory T-cell checkpoint blocked to potentiate immune responses, often combined with anti-PD-1.